Request the sensitive or ultrasensitive assay for accurate readings
Sakuma S, Ishimura M, Yuba Y, et al
Key Benefits of BPC-157 Peptide Therapy At Southern Care Anesthetics in Hattiesburg, MS, BPC-157 peptide therapy accelerates recovery by promoting the healing of muscles, tendons, and ligaments
In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
BPC-157 accelerates granulation tissue maturation, potentially allowing wounds to progress through this phase more efficiently
